Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025BloodOpen Access

Single-nucleus dissection of peripheral T-cell lymphomas reveals distinct microenvironmental ecosystems and therapeutic vulnerabilities

View Full Paper
Ask AI
Bookmark
Share

Authors

BSBobby B. ShihLPLaura Quevedo PalacioALAnouchka P. Laurent

Discussion

Loading...

Member takes

Overview

Integrated analysis reveals chromosomal abnormalities and distinct tumor microenvironments in peripheral T-cell lymphomas, suggesting new therapeutic vulnerabilities.

Key Points

  • Malignant T cells exhibited chromosomal abnormalities, indicating substantial heterogeneity and varying therapeutic vulnerabilities in lymphoma.
  • Analysis identified distinct tumor microenvironments, with unique types like cancer-associated fibroblasts influencing tumor growth.
  • Single-nucleus RNA sequencing and mutational profiling were employed on samples to characterize complex cell interactions and states.
  • These findings may support targeted intervention strategies by elucidating unique cellular pathways in peripheral T-cell lymphomas.

Cite This Study

Shih et al. (2025) studied this question.

synapsesocial.com/papers/69362f4b4fa91c937236d766https://doi.org/10.1182/blood-2025-1787
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Spatial transcriptomic analysis of chronic lymphocytic leukemia lymph nodes reveals tumor microenvironment evolution during disease progression2025
  2. 2Multi-dimensional transcriptomic profiling reveals novel tumor microenvironment landscape and subtype-specific therapeutic Vulnerabilities of MALT lymphomas2025
  3. 3Case Report: Cutaneous niche-restricted malignant phenotypes in PTCL-NOS revealed by single-cell sequencing2026
  4. 4CDK7 enables adaptive gene transcription required by stromal cells to support distinct T-cell lymphoma phenotypes and represents a novel microenvironment-directed therapeutic target2025
  5. 5Unraveling the distinct biology of ATLL: Clinical and genetic divergence from other peripheral T-cell lymphomas2025